Patents by Inventor Yoshitomo Chujo

Yoshitomo Chujo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds
    Patent number: 7279484
    Abstract: The inventive subject matter relates to compounds, pharmaceutical compositions, and kits containing a heterocyclic compound represented by the formula (I) wherein R is an alkyl group optionally having substituent(s) etc., X is an amino group optionally having substituent(s), Y1 and Y2 are nitrogen atoms etc., an isomer or solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: October 9, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Tatsuhiro Yamada, Tadakiyo Nakagawa, Yasuhiro Tanaka, Kohichi Fujita, Tomoyuki Tagami, Yuka Ikenoue, Shunsuke Fukuda, Yoshitomo Chujo, Manabu Suzuki, Masahiro Murata
  • Heterocyclic compounds
    Publication number: 20050250796
    Abstract: The inventive subject matter relates to compounds, pharmaceutical compositions, and kits containing a heterocyclic compound represented by the formula (I) wherein R is an alkyl group optionally having substituent(s) etc., X is an amino group optionally having substituent(s), Y1 and Y2 are nitrogen atoms etc., an isomer or solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: April 28, 2005
    Publication date: November 10, 2005
    Inventors: Tatsuhiro Yamada, Tadakiyo Nakagawa, Yasuhiro Tanaka, Kohichi Fujita, Tomoyuki Tagami, Yuka Ikenoue, Shunsuke Fukuda, Yoshitomo Chujo, Manabu Suzuki, Masahiro Murata
  • Anti-AIDS secretory recombinant BCG vaccine
    Patent number: 5885580
    Abstract: A vaccine containing Mycobacterium bovis BCG which secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of a secretory protein, a carrier, having a signal peptide. BCG constituting the present invention secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of an .alpha.-antigen derived from mycobacteria. Said fusion protein has significantly increased antigenicity and immunogenicity. Therefore, when it is inoculated into animals, it is efficiently recognized by B cells which recognize said antigen, thereby effectively inducing the production of an antibody to said antigen. When said BCG itself is inoculated into animals, it continuously secretes said fusion protein in the bodies of the animals while continuously propagating therein. Therefore, said BCG is an extremely useful vaccine.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: March 23, 1999
    Assignees: Ajinomoto Co., Inc., Japan as represented by Director General of Agency of National Institute of Health
    Inventors: Kazuhiro Matsuo, Yoshitomo Chujo, Akihiro Yamazaki, Mitsuo Honda, Shudo Yamazaki, Hiromichi Tasaka
  • Anti-acids secretory recombinant BCG vaccine
    Patent number: 5858369
    Abstract: A vaccine containing Mycobacterium bovis BCG which secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of a secretory protein, a carrier, having a signal peptide. BCG constituting the present invention secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of an .alpha.-antigen derived from mycobacteria. Said fusion protein has significantly increased antigenicity and immunogenicity. Therefore, when it is inoculated into animals, it is efficiently recognized by B cells which recognize said antigen, thereby effectively inducing the production of an antibody to said antigen. When said BCG itself is inoculated into animals, it continuously secretes said fusion protein in the bodies of the animals while continuously propagating therein. Therefore, said BCG is an extremely useful vaccine.
    Type: Grant
    Filed: November 21, 1997
    Date of Patent: January 12, 1999
    Assignees: Ajinomoto Co., Inc., Japan as represented by Director General of Agency of National Institute of Health
    Inventors: Kazuhiro Matsuo, Yoshitomo Chujo, Akihiro Yamazaki, Mitsuo Honda, Shudo Yamazaki, Hiromichi Tasaka